Steroid Tapering Regimen for Bell's Palsy
For Bell's palsy in patients 16 years and older, prescribe prednisone 60 mg daily for 5 days, then taper by 10 mg per day over the next 5 days (total 10-day course), initiated within 72 hours of symptom onset. 1
Recommended Dosing Protocols
The American Academy of Otolaryngology-Head and Neck Surgery guideline provides two evidence-based options 1:
Option 1 (Preferred):
- Prednisone 60 mg daily for 5 days
- Then taper by 10 mg daily over 5 days
- Total duration: 10 days
Option 2 (Alternative):
- Prednisolone 25 mg twice daily (50 mg total) for 10 days (no taper)
Both regimens are supported by high-quality randomized controlled trials (Sullivan et al. and Engstrom et al.) that demonstrated significant improvement in facial nerve recovery 1, 2. The tapering regimen showed 94.4% recovery at 9 months versus 81.6% with placebo 1.
Critical Timing Considerations
- Must initiate within 72 hours of symptom onset for maximum benefit 1, 3
- Treatment after 72 hours has unclear benefit 1
- Administer in the morning (prior to 9 am) to minimize HPA axis suppression 4
- 94.56% of patients in real-world practice receive treatment on the index date 5
Evidence Quality and Reasoning
The strong recommendation is based on two landmark trials 1:
- Sullivan et al.: 83% recovery at 3 months with prednisolone versus 63.6% with placebo (p<0.001)
- Engstrom et al.: Significantly shorter time to recovery in 416 patients treated with prednisolone versus 413 without
The tapering approach (60 mg × 5 days, then taper) is preferred over flat dosing because it balances efficacy with safety, allowing gradual HPA axis recovery while maintaining therapeutic benefit 1, 6.
Important Clinical Caveats
Prognostic factors predicting poor outcome (requiring more aggressive monitoring, not higher doses) 6:
- Treatment delay >7 days (RR=18.87)
- Severe facial paralysis at presentation (RR=5.01)
- Hearing defect (RR=3.01)
- History of recurrence (RR=3.75)
Do NOT use antiviral monotherapy - it provides no benefit over placebo 1, 3. Combination therapy with antivirals may be offered as an option but is not required 3.
Avoid abrupt discontinuation - the taper is essential to prevent adrenal insufficiency after 10 days of high-dose therapy 4.
Special Populations
Children (<16 years): Evidence is inconclusive, but the same regimen may be considered given similar disease pathophysiology and favorable benefit-harm ratio, with caregiver involvement in decision-making 1.
Severe paralysis (House-Brackmann Grade IV): Some evidence suggests higher-dose IV methylprednisolone may provide faster 1-month recovery, but no difference at 3 months 7. The standard oral regimen remains appropriate.
Real-World Practice Gap
Only 51.9% of Bell's palsy patients receive guideline-concordant steroid therapy 5, indicating significant undertreatment. The evidence overwhelmingly supports early corticosteroid use as the single most effective intervention for improving facial nerve recovery and reducing long-term morbidity.